ArticleTranslational cancer research2024

Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases.

Xuexia Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.